Radient Pharmaceuticals Corporation fka RXPC

[lakeshore555]

Radient removed the January 18 2011 PR from its website, but you can still find it here:

http://www.marketwire.com/press-release/radient-pharmaceuticals-announces-progress-potential-completion-date-its-onko-surer-nyse-amex-rpc-1381430.htm

The problematic lines, IMO:

"...announced today progress on its clinical study with Mayo Clinic ("Mayo") for the validation of the Company's US FDA-cleared Onko-Sure® in vitro diagnostic (IVD) cancer test..."

AND

"Based on recent advancements, RPC anticipates it will complete the clinical trial with Mayo in the first quarter of 2011."

These are problematic because there was no "clinical study with Mayo" - there was a clinical study in which Mayo tested some blood samples with CEA, sold those samples to Radient, and Radient tersted the same samples with DR-70.

It wasn't a clinical trial, but specifically, it wasn't a "clinical trial with Mayo."

It's also questionable the way MacLellan stated "To have internationally recognized leaders in oncology take such great interest in Onko-Sure® is a testament to the importance of the test." Is he implying that the Mayo Clinic is the internationally recognized leader that took interest in onko-sure? Because they did NOT.

It all boils down to whether a jury thinks Radient intended to deceive. I think the jury will find Radient guilty, especially since the Mayo Clinic felt the need to issue a subsequent press release stating:

" Mayo is not engaged in clinical studies with Radient and does not have a partnership agreement with Radient. "

http://newsblog.mayoclinic.org/2011/03/07/mayo-response-to-radient-article/